BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33678071)

  • 1. Assessment of HIV testing recommendations in Greek specialty guidelines: A missed opportunity and room for improvement for recommending testing.
    Akinosoglou K; Kostaki EG; Paraskevis D; Gogos CA
    AIDS Care; 2021 Oct; 33(10):1312-1315. PubMed ID: 33678071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
    Lord E; Stockdale AJ; Malek R; Rae C; Sperle I; Raben D; Freedman A; Churchill D; Lundgren J; Sullivan AK;
    HIV Med; 2017 Apr; 18(4):300-304. PubMed ID: 27535357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of HIV testing recommendations in Australian specialty guidelines for HIV indicator conditions: a missed opportunity for recommending testing?
    Lin YD; Eades L; Nair A; Korman TM; Woolley I
    Intern Med J; 2020 Mar; 50(3):293-298. PubMed ID: 31566841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
    Jordans CCE; Vasylyev M; Rae C; Jakobsen ML; Vassilenko A; Dauby N; Grevsen AL; Jakobsen SF; Raahauge A; Champenois K; Papot E; Malin JJ; Boender TS; Behrens GMN; Gruell H; Neumann A; Spinner CD; Valbert F; Akinosoglou K; Kostaki EG; Nozza S; Giacomelli A; Lapadula G; Mazzitelli M; Torti C; Matulionyte R; Matulyte E; Van Welzen BJ; Hensley KS; Thompson M; Ankiersztejn-Bartczak M; Skrzat-Klapaczyńska A; Săndulescu O; Streinu-Cercel A; Streinu-Cercel A; Miron VD; Pokrovskaya A; Hachfeld A; Dorokhina A; Sukach M; Lord E; Sullivan AK; Rokx C;
    Euro Surveill; 2022 Dec; 27(48):. PubMed ID: 36695464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study.
    Bogers SJ; Schim van der Loeff MF; Davidovich U; Boyd A; van der Valk M; Brinkman K; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
    BMC Infect Dis; 2021 Jun; 21(1):519. PubMed ID: 34078315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing indicator condition-guided HIV testing in Taiwan: a nationwide case-control study from 2009 to 2015.
    Lee CY; Lin YP; Lin CY; Lu PL; Liang FW
    BMC Public Health; 2024 Apr; 24(1):967. PubMed ID: 38580963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
    Raben D; Mocroft A; Rayment M; Mitsura VM; Hadziosmanovic V; Sthoeger ZM; Palfreeman A; Morris S; Kutsyna G; Vassilenko A; Minton J; Necsoi C; Estrada VP; Grzeszczuk A; Johansson VS; Begovac J; Ong EL; Cabié A; Ajana F; Celesia BM; Maltez F; Kitchen M; Comi L; Dragsted UB; Clumeck N; Gatell J; Gazzard B; d'Arminio Monforte A; Rockstroh J; Yazdanpanah Y; Champenois K; Jakobsen ML; Sullivan A; Lundgren JD;
    PLoS One; 2015; 10(11):e0140845. PubMed ID: 26560105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.
    Raben D; Sullivan AK; Mocroft A; Kutsyna G; Hadžiosmanović V; Vassilenko A; Chkhartisvili N; Mitsura V; Pedersen C; Anderson J; Begovac J; Bak Dragsted U; Bertisch B; Grzeszczuk A; Minton J; Necsoi VC; Kitchen M; Ajana F; Sokhan A; Comi L; Farazmand P; Pesut D; De Wit S; Gatell JM; Gazzard B; d'Arminio Monforte A; Rockstroh JK; Yazdanpanah Y; Champenois K; Jakobsen ML; Lundgren JD;
    PLoS One; 2019; 14(8):e0220108. PubMed ID: 31408476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General practitioners' barriers and facilitators towards new provider-initiated HIV testing strategies: a qualitative study.
    Joore IK; van Roosmalen SL; van Bergen JE; van Dijk N
    Int J STD AIDS; 2017 Apr; 28(5):459-466. PubMed ID: 27207253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care.
    Joore IK; Twisk DE; Vanrolleghem AM; de Ridder M; Geerlings SE; van Bergen JE; van den Broek IV
    BMC Fam Pract; 2016 Nov; 17(1):161. PubMed ID: 27855639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking missed opportunities for an early HIV diagnosis in a population of people living with HIV with known time of infection.
    Basoulis D; Kostaki EG; Paraskevis D; Hatzakis A; Psichogiou M
    Sex Transm Infect; 2022 Mar; 98(2):79-84. PubMed ID: 33608478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?
    Lin YD; Garner SE; Lau JSY; Korman TM; Woolley IJ
    QJM; 2019 Jan; 112(1):17-21. PubMed ID: 30295832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities.
    van den Bogaart L; Ranzani A; Oreni L; Giacomelli A; Corbellino M; Rusconi S; Galli M; Antinori S; Ridolfo AL
    Eur J Intern Med; 2020 Mar; 73():30-35. PubMed ID: 31635999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed opportunities for HIV testing persist despite a single educational intervention: how can we close this evidence-practice gap?
    King K; Seah J; Cheng A; Whiting S; Hoy J
    Intern Med J; 2020 Mar; 50(3):285-292. PubMed ID: 31276275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed opportunities for HIV testing and sexual health-related challenges in an individual with intellectual disability: a case report.
    Würfel LM; Potthoff A; Nambiar S; Skaletz-Rorowski A
    AIDS Res Ther; 2024 Apr; 21(1):20. PubMed ID: 38581028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.
    Merz L; Zimmermann S; Peters S; Cavassini M; Darling KE
    Oncologist; 2016 Oct; 21(10):1176-1182. PubMed ID: 27440062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV testing in Lanarkshire.
    Acquah RR; Baggott A; McGoldrick C; Kennedy N
    J R Coll Physicians Edinb; 2014; 44(4):278-82. PubMed ID: 25516895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions.
    Menacho I; Sequeira E; Muns M; Barba O; Leal L; Clusa T; Fernandez E; Moreno L; Raben D; Lundgren J; Gatell JM; Garcia F; Cayuelas L; Aragunde V; Vergara M; Catalan M; Moreno MA; Hormigo G; Siso A; Herreras Z; Sebastian L; Benito L; Picas A; Hoyo J; Giner MJ; Cararach D; Moles E; Moro ML; Arrabal P; Roca D; Prego S; Ferrer X; Egido A; Ventosa C; Garcia S; Muñoz S; Massana A; Sole J; Curiel M; Heras F; Leon A
    HIV Med; 2013 Oct; 14 Suppl 3():33-7. PubMed ID: 24033901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV testing in patients presenting with indicator conditions in outpatient settings: offer and uptake rates, and educational and active interventions.
    Youssef E; Sanghera T; Bexley A; Hayes M; Perry N; Dosekun O; Perera S
    Int J STD AIDS; 2018 Nov; 29(13):1289-1294. PubMed ID: 29979144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital.
    Mosimann V; Cavassini M; Hugli O; Mamin R; Achtari C; Peters S; Darling KE
    HIV Med; 2014 Nov; 15(10):631-4. PubMed ID: 25102762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.